Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · IEX Real-Time Price · USD
3.55
+0.19 (5.65%)
At close:
Mar 17, 2023, 4:00 PM
3.38
-0.17 (-4.79%)
Pre-market:
Mar 20, 2023, 8:22 AM EDT
Cash Flow Statement (Annual)
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Year | 2022 | 2021 | 2020 |
---|---|---|---|
Net Income | -9.41 | -3.72 | -0.41 |
Depreciation & Amortization | 0.11 | 0 | 0 |
Share-Based Compensation | 1.65 | 0.85 | 0 |
Other Operating Activities | 2.57 | 0.04 | 0.15 |
Operating Cash Flow | -5.08 | -2.84 | -0.26 |
Capital Expenditures | -0.01 | -0.03 | -0.01 |
Other Investing Activities | - | -0.22 | 0 |
Investing Cash Flow | -0.01 | -0.25 | -0.01 |
Share Issuance / Repurchase | 0.8 | 7.36 | 0.6 |
Debt Issued / Paid | -0.08 | 0 | 0 |
Other Financing Activities | -0.02 | - | - |
Financing Cash Flow | 0.7 | 7.36 | 0.6 |
Net Cash Flow | -4.42 | 4.27 | 0.33 |
Free Cash Flow | -5.09 | -2.87 | -0.27 |
Free Cash Flow Per Share | -3.92 | -3.09 | -0.51 |
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).